,2 5.C2 3<B;1 A5.A D52; :.;.42?@ ?.;8 A526? <=A6<;@ 6;
A56@ D.F 6A .99<D@ A52: A< 12A2?:6;2 D5605 =?<720A@ A<
B;12?A.82 L?@A /.@21 <; A52 C.9B2 A52F =?<C612 0<:=.?21
D6A5<A52?0<:=.;F?2@6962;026;6A6.A6C2@
Option Valuation in a
Pharmaceutical Supply Chain
)< 12:<;@A?.A2 A52 BA696AF <3 A52 <=A6<; C.9B.A6<; :2A5<1@
D2 B@21 6A A< .@@2@@ 233<?A@ /F . =5.?:.02BA60.9 0<:=.;F
A< :.82 =?<.0A6C2 ?2@6962;02 =9.;@ B?6;4 A52 $+
=.;12:60 A52 0<:=.;F D.@ 0<;3?<;A21 /F <;2 <3 6A@
@B==962?@ 12:.;16;4 . ;2D 2E09B@6C2 9<;4A2?: 0<;A?.0A .A
. 56452? =?602 )52 0<:=.;F ?2.96G21 A5.A .;F <3 6A@ 0?6A60.9
@B==962@ 0<B91 /2 .A ?6@8 .;1 .A A52 D<?@A =<@@6/92 A6:2
.;1 A5.A D6A5<BA /.08B= @B==962?@ 6A 0<B91 3.02 . =<A2;A6.99F
12C.@A.A6;49<@@<3?2C2;B2@
<D2C2? ...